A Missouri judge gave final approval to Bayer's nationwide settlement that could cost up to $7.25 billion, compensating thousands diagnosed with non‑Hodgkin lymphoma.
A Missouri judge gave final approval to Bayer's nationwide settlement that could cost up to $7.25 billion, compensating thousands diagnosed with non‑Hodgkin lymphoma.